Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Receivables (2018 - 2019)

DiaMedica Therapeutics' Receivables history spans 2 years, with the latest figure at $1.3 million for Q3 2019.

  • For Q3 2019, Receivables changed N/A year-over-year to $1.3 million; the TTM value through Sep 2019 reached $1.3 million, changed N/A, while the annual FY2018 figure was $1.4 million, N/A changed from the prior year.
  • Receivables reached $1.3 million in Q3 2019 per DMAC's latest filing, down from $2.1 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $2.1 million in Q2 2019 to a low of $976000.0 in Q1 2019.